Atrophied Lesion Volume as a Biomarker of Disability in Progressive Multiple Sclerosis
June 29th 2021Robert Zivadinov, MD, PhD, director, Buffalo Neuroimaging Analysis Center, spoke to the findings of a post-hoc analysis of atrophied T2-lesion volume as a biomarker in patients with progressive MS.
Clinical Takeaways From INP104 Data in Migraine: Sheena K. Aurora, MD
June 26th 2021The vice president of Medical Affairs in Migraine at Impel discussed the clinical takeaways from the STOP 301 trial of intranasal DHE and the advantages that the novel formulation might offer patients with migraine.
Changing Multidisciplinary Care: Integration of Advanced Practice Clinicians in Neurology
June 25th 2021Calli L. Cook, NP, DNP, nurse practitioner, Woodruff School of Nursing, Emory University, detailed her vision for creating change within the neurology field by incorporating advanced practice clinicians.